Efficacy and safety of semaglutide combined with metformin in treating T2DM with overweight or obesity: a systematic review and meta-analysis.

Juan LiKui LiZhaoyun LiuHuiwen YuJie Zhang

Published in: American journal of translational research (2024)

Treatment with semaglutide combined with metformin significantly improved glycemic control, insulin resistance, weight, BMI, and lipid profiles in patients with T2DM who are overweight or obese.

Keyphrases

glycemic control
weight loss
bariatric surgery
insulin resistance
weight gain
blood glucose
type diabetes
body mass index
metabolic syndrome
adipose tissue
obese patients
high fat diet
fatty acid
skeletal muscle
high fat diet induced
polycystic ovary syndrome
combination therapy